Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Scavenger receptor class F member 1 (SREC-I), also known as SCARF1, is a type I transmembrane protein that functions as a scavenger receptor on endothelial cells and antigen-presenting cells (APCs) such as dendritic cells and macrophages (UniProt Q9UHF0). It plays a pivotal role in the immune system by mediating the uptake of a wide range of ligands, including acetylated low-density lipoproteins, heat shock proteins (HSPs), and apoptotic cells (PubMed: 17641034). On APCs, SREC-I is particularly important for its ability to bind HSP-antigen complexes, facilitating their internalization and subsequent cross-presentation to CD8+ T cells, which is a critical step in generating anti-tumor immune responses (PubMed: 25108027). Furthermore, SREC-I is essential for efferocytosis, the process of clearing apoptotic debris; a deficiency in this receptor is linked to the development of systemic lupus erythematosus (SLE) due to the accumulation of autoantigens (PubMed: 21606508). In therapeutic development, SREC-I is targeted by investigational cancer vaccines, such as those using HSP70-peptide complexes, to enhance the delivery of tumor antigens to the immune system. It also serves as a potential entry point for various pathogens, including certain viruses and fungi, making it a target for research into anti-infective strategies.
SREC-I facilitates the binding and internalization of heat shock protein (HSP)-antigen complexes via receptor-mediated endocytosis, leading to the trafficking of antigens into the cross-presentation pathway for activation of CD8+ T cells.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Scavenger receptor class F member 1 (SREC-I) (SCARF1).